Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 6 studies | 21% ± 5% | |
GABAergic neuron | 3 studies | 36% ± 3% | |
glutamatergic neuron | 3 studies | 40% ± 5% | |
astrocyte | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 32% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1441.09 | 2640 / 2642 | 100% | 22.57 | 705 / 705 |
prostate | 100% | 1060.27 | 245 / 245 | 100% | 14.14 | 501 / 502 |
stomach | 100% | 776.36 | 358 / 359 | 100% | 11.06 | 286 / 286 |
adrenal gland | 100% | 1734.06 | 258 / 258 | 100% | 19.93 | 229 / 230 |
ovary | 100% | 1452.62 | 180 / 180 | 100% | 12.60 | 428 / 430 |
liver | 100% | 1224.15 | 226 / 226 | 100% | 12.61 | 404 / 406 |
breast | 100% | 1323.11 | 459 / 459 | 99% | 16.02 | 1112 / 1118 |
esophagus | 100% | 837.28 | 1445 / 1445 | 99% | 9.29 | 182 / 183 |
kidney | 100% | 847.91 | 89 / 89 | 99% | 13.05 | 896 / 901 |
bladder | 100% | 1007.67 | 21 / 21 | 99% | 9.99 | 501 / 504 |
thymus | 100% | 1093.84 | 653 / 653 | 99% | 14.12 | 601 / 605 |
lung | 100% | 957.90 | 577 / 578 | 99% | 9.70 | 1149 / 1155 |
intestine | 100% | 1206.29 | 966 / 966 | 99% | 11.21 | 523 / 527 |
pancreas | 100% | 772.88 | 328 / 328 | 99% | 9.26 | 176 / 178 |
uterus | 100% | 1315.52 | 170 / 170 | 99% | 9.71 | 453 / 459 |
skin | 100% | 1381.98 | 1809 / 1809 | 98% | 11.37 | 464 / 472 |
adipose | 100% | 1241.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.72 | 29 / 29 |
spleen | 100% | 800.96 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.71 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.05 | 1 / 1 |
blood vessel | 100% | 1005.44 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 935.87 | 802 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 11.24 | 79 / 80 |
heart | 96% | 669.32 | 829 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 70% | 316.94 | 651 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000422 | Biological process | autophagy of mitochondrion |
GO_1901525 | Biological process | negative regulation of mitophagy |
GO_0000425 | Biological process | pexophagy |
GO_0008053 | Biological process | mitochondrial fusion |
GO_0035871 | Biological process | protein K11-linked deubiquitination |
GO_0006508 | Biological process | proteolysis |
GO_0044313 | Biological process | protein K6-linked deubiquitination |
GO_0016579 | Biological process | protein deubiquitination |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0101005 | Molecular function | deubiquitinase activity |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
Gene name | USP30 |
Protein name | Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30) Ubiquitin carboxyl-terminal hydrolase (EC 3.4.19.12) Ubiquitin specific peptidase 30 Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) |
Synonyms | |
Description | FUNCTION: Deubiquitinating enzyme tethered to the mitochondrial outer membrane that acts as a key inhibitor of mitophagy by counteracting the action of parkin (PRKN): hydrolyzes ubiquitin attached by parkin on target proteins, such as RHOT1/MIRO1 and TOMM20, thereby blocking parkin's ability to drive mitophagy . Preferentially cleaves 'Lys-6'- and 'Lys-11'-linked polyubiquitin chains, 2 types of linkage that participate in mitophagic signaling . Does not cleave efficiently polyubiquitin phosphorylated at 'Ser-65' . Acts as a negative regulator of mitochondrial fusion by mediating deubiquitination of MFN1 and MFN2 (By similarity). . FUNCTION: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes. . |
Accessions | ENST00000392784.6 ENST00000539121.1 ENST00000377883.7 ENST00000536393.5 S4R3D1 Q70CQ3 F5GXG2 ENST00000470117.2 F5H8D3 ENST00000536723.5 F5H3L3 ENST00000257548.10 S4R354 B3KUS5 |